Cybin Inc (CYBN)
0.2532
-0.01
(-4.09%)
USD |
NYAM |
Jun 26, 13:35
Cybin Price to Book Value: 1.139 for June 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 25, 2024 | 1.187 |
| June 24, 2024 | 1.187 |
| June 21, 2024 | 1.187 |
| June 20, 2024 | 1.199 |
| June 18, 2024 | 1.223 |
| June 17, 2024 | 1.222 |
| June 14, 2024 | 1.300 |
| June 13, 2024 | 1.304 |
| June 12, 2024 | 1.344 |
| June 11, 2024 | 1.364 |
| June 10, 2024 | 1.277 |
| June 07, 2024 | 1.303 |
| June 06, 2024 | 1.302 |
| June 05, 2024 | 1.349 |
| June 04, 2024 | 1.493 |
| June 03, 2024 | 1.55 |
| May 31, 2024 | 1.574 |
| May 30, 2024 | 1.572 |
| May 29, 2024 | 1.572 |
| May 28, 2024 | 1.573 |
| May 24, 2024 | 1.601 |
| May 23, 2024 | 1.569 |
| May 22, 2024 | 1.618 |
| May 21, 2024 | 1.596 |
| May 20, 2024 | 1.578 |
| Date | Value |
|---|---|
| May 17, 2024 | 1.574 |
| May 16, 2024 | 1.583 |
| May 15, 2024 | 1.574 |
| May 14, 2024 | 1.537 |
| May 13, 2024 | 1.546 |
| May 10, 2024 | 1.63 |
| May 09, 2024 | 1.681 |
| May 08, 2024 | 1.664 |
| May 07, 2024 | 1.659 |
| May 06, 2024 | 1.655 |
| May 03, 2024 | 1.574 |
| May 02, 2024 | 1.574 |
| May 01, 2024 | 1.574 |
| April 30, 2024 | 1.574 |
| April 29, 2024 | 1.574 |
| April 26, 2024 | 1.574 |
| April 25, 2024 | 1.556 |
| April 24, 2024 | 1.596 |
| April 23, 2024 | 1.596 |
| April 22, 2024 | 1.621 |
| April 19, 2024 | 1.653 |
| April 18, 2024 | 1.663 |
| April 17, 2024 | 1.688 |
| April 16, 2024 | 1.707 |
| April 15, 2024 | 1.667 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9958
Minimum
Dec 16 2022
2099.12
Maximum
Dec 17 2020
47.63
Average
2.461
Median
Price to Book Value Benchmarks
| Clearmind Medicine Inc | 0.9406 |
| Acasti Pharma Inc | 58.62 |
| Aurinia Pharmaceuticals Inc | 2.089 |
| Edesa Biotech Inc | 3.124 |
| Lexaria Bioscience Corp | 4.960 |
Price to Book Value Related Metrics
| Price | 0.2532 |
| Earnings Yield | -82.03% |
| Market Cap | 104.04M |